» Articles » PMID: 21394175

Prostate Cancer: Diagnostic Performance of the PCA3 Urine Test

Overview
Journal Nat Rev Urol
Specialty Urology
Date 2011 Mar 12
PMID 21394175
Citations 87
Authors
Affiliations
Soon will be listed here.
Citing Articles

Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy.

Zabeti Touchaei A, Norollahi S, Najafizadeh A, Babaei K, Bakhshalipour E, Vahidi S Cancer Cell Int. 2024; 24(1):334.

PMID: 39369258 PMC: 11453077. DOI: 10.1186/s12935-024-03514-y.


Unveiling potential: urinary exosomal mRNAs as non-invasive biomarkers for early prostate cancer diagnosis.

Yu J, Yu C, Jiang K, Yang G, Yang S, Tan S BMC Urol. 2024; 24(1):163.

PMID: 39090720 PMC: 11292860. DOI: 10.1186/s12894-024-01540-6.


Exploring the translational landscape of the long noncoding RNA transcriptome in acute respiratory distress syndrome: it is a long way to the top.

Belmonte T, Rodriguez-Munoz C, Ferruelo A, Exojo-Ramirez S, Amado-Rodriguez L, Barbe F Eur Respir Rev. 2024; 33(172).

PMID: 38925793 PMC: 11216684. DOI: 10.1183/16000617.0013-2024.


Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.

Davoudi F, Moradi A, Becker T, Lock J, Abbey B, Fontanarosa D Curr Treat Options Oncol. 2023; 24(10):1451-1471.

PMID: 37561382 PMC: 10547634. DOI: 10.1007/s11864-023-01121-z.


A simple urine test by 3D-plus-3D immunoassay guides precise cancer diagnosis.

Kim H, Moon O, Seol Y, Lee J Bioeng Transl Med. 2023; 8(3):e10489.

PMID: 37206218 PMC: 10189436. DOI: 10.1002/btm2.10489.


References
1.
Auprich M, Haese A, Walz J, Pummer K, De La Taille A, Graefen M . External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome. Eur Urol. 2010; 58(5):727-32. DOI: 10.1016/j.eururo.2010.06.038. View

2.
Haese A, De La Taille A, van Poppel H, Marberger M, Stenzl A, Mulders P . Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur Urol. 2008; 54(5):1081-8. DOI: 10.1016/j.eururo.2008.06.071. View

3.
Hessels D, Klein Gunnewiek J, van Oort I, Karthaus H, van Leenders G, van Balken B . DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003; 44(1):8-15; discussion 15-6. DOI: 10.1016/s0302-2838(03)00201-x. View

4.
Marks L, Fradet Y, Deras I, Blase A, Mathis J, Aubin S . PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology. 2007; 69(3):532-5. DOI: 10.1016/j.urology.2006.12.014. View

5.
Ploussard G, De La Taille A . Urine biomarkers in prostate cancer. Nat Rev Urol. 2010; 7(2):101-9. DOI: 10.1038/nrurol.2009.261. View